|
1
|
Ben-Porath I and Benvenisty N:
Characterization of a tumor-associated gene, a member of a novel
family of genes encoding membrane glycoproteins. Gene. 183:69–75.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor V and Suter U: Epithelial membrane
protein-2 and epithelial membrane protein-3: Two novel members of
the peripheral myelin protein 22 gene family. Gene. 175:115–120.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ben-Porath I, Kozak CA and Benvenisty N:
Chromosomal mapping of Tmp (Emp1), Xmp (Emp2) and Ymp (Emp3), genes
encoding membrane proteins related to Pmp22. Genomics. 49:443–447.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiemann S, Ruckels M, Engelholm LH,
Schwirzke M, Brünner N and Weidle UH: Differential gene expression
in human mammary carcinoma cells: Identification of a new member of
a receptor family. Anticancer Res. 17:13–20. 1997.PubMed/NCBI
|
|
5
|
Mackay A, Jones C, Dexter T, Silva RL,
Bulmer K, Jones A, Simpson P, Harris RA, Jat PS, Neville AM, et al:
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu)
overexpression in human mammary luminal epithelial cells. Oncogene.
22:2680–2688. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Evtimova V, Zeillinger R and Weidle UH:
Identification of genes associated with the invasive status of
human mammary carcinoma cell lines by transcriptional profiling.
Tumour Biol. 24:189–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hutvagner G and Zamore PD: A microRNA in a
multiple-turnover RNAi enzyme complex. Science. 297:2056–2060.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W,
Chang G, Li X, Li Q, Wang S, et al: MicroRNA profiling implies new
markers of chemoresistance of triple-negative breast cancer. PLoS
One. 9:e962282014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leung YK, Chan QK, Ng CF, Ma FM, Tse HM,
To KF, Maranchie J, Ho SM and Lau KM: Hsa-miRNA-765 as a key
mediator for inhibiting growth, migration and invasion in
fulvestrant-treated prostate cancer. PLoS One. 9:e980372014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou W, Jiang Z, Li X, Xu F, Liu Y, Wen P,
Kong L, Hou M and Yu J: EMP3 overexpression in primary breast
carcinomas is not associated with epigenetic aberrations. J Korean
Med Sci. 24:97–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YC, Wei LJ, Liu JT, Li SX and Wang
QS: Comparison of cancer incidence between China and the USA.
Cancer Biol Med. 9:128–132. 2012.
|
|
13
|
Tinoco G, Warsch S, Gluck S, Avancha K and
Montero AJ: Treating breast cancer in the 21st century: Emerging
biological therapies. J Cancer. 4:117–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alphandéry E: Perspectives of breast
cancer thermotherapies. J Cancer. 5:472–479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xue Q, Zhou Y, Wan C, Lv L, Chen B, Cao X,
Ju G, Huang Y, Ni R and Mao G: Epithelial membrane protein 3 is
frequently shown as promoter methylation and functions as a tumor
suppressor gene in non-small cell lung cancer. Exp Mol Pathol.
95:313–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang Z, Zhou W, Li XG, Jiang YQ, Wang L,
Wang DH, Wang XY and Li XE: The methylation analysis of EMP3 and
PCDH-gamma-A11 gene in human glioma. Zhonghua Wai Ke Za Zhi.
48:300–304. 2010.In Chinese. PubMed/NCBI
|
|
17
|
Li KK, Pang JC, Chung NY, Ng YL, Chan NH,
Zhou L, Poon WS and Ng HK: EMP3 overexpression is associated with
oligodendroglial tumors retaining chromosome arms 1p and 19q. Int J
Cancer. 120:947–950. 2007. View Article : Google Scholar
|
|
18
|
Pasini A, Iorio P, Bianchi E, Cerasoli S,
Cremonini AM, Faedi M, Guarnieri C, Guiducci G, Riccioni L,
Molinari C, et al: LOH 19q indicates shorter disease
progression-free interval in low-grade oligodendrogliomas with EMP3
methylation. Oncol Rep. 28:2271–2277. 2012.PubMed/NCBI
|
|
19
|
Fabbri M: miRNAs as molecular biomarkers
of cancer. Expert Rev Mol Diagn. 10:435–444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leung AK and Sharp PA: MicroRNA functions
in stress responses. Mol Cell. 40:205–215. 2010. View Article : Google Scholar : PubMed/NCBI
|
